树脂上的固相合成——(一)多肽、低聚核苷酸、寡糖的固相合成

综述了典型的固相合成法,及其在多肽、低聚核苷酸和寡糖合成中的应用。比较了固相合成法与传统的液相合成法之优缺点。介绍了固相合成法中常用的高分子载体;氨基、羧基、羟基、磷酸基等功能基的化学保护方法。介绍了1984年诺贝尔奖金获得者,固相合成创始人R.B.Merrifield在此领域中的成就。引用了1963～1986年的60篇文献。     

固相多肽合成中Dmab保护基的脱除研究

在固相多肽合成中,Dmab作为羧基保护基具有脱保护条件温和、步骤简便、选择性高的特点,但有时脱保护效率并不稳定.为此,基于Fmoc/t Bu/Dmab三维正交保护策略,利用固相多肽合成技术设计并合成了4个肽树脂,对固相多肽合成中Glu和Asp主链和侧链羧基的Dmab保护基脱除规律进行了研究.结果显示,树脂上α-ODmab的脱保护快速、完全,β-ODmab和γ-ODmab脱保护反应较慢,可以检测到相应的中间产物(4-氨基苄酯肽),推测脱保护效率由快到慢依次为α-ODmabβ-ODmabγ-ODmab.该结果表明Dmab作为α-COOH保护基具有较高的应用价值,但用于β-COOH和γ-COOH保护时,其脱保护条件尚不成熟.     

血红蛋白片段的合成及生物活性

采用多肽固相合成方法, 以Wang 树脂为载体, Fmoc为N-端氨基酸保护基, HOBt-HBTU为缩合试剂, 合成了一系列血红蛋白α链的片段, 产物经RP-HPLC和质谱进行了确定. 生物活性研究结果表明, 该系列多肽具有较高的血管紧张素Ⅰ转换酶抑制活性, 但不具有α-葡萄糖苷酶抑制活性.     

丙戊酰酪氨酸二肽Tyr-Tyr-VPA的固相合成

以Wang树脂为固相载体,Fmoc-为α-氨基保护基,HBTU-HOBT为缩合剂,采用多肽固相合成方法合成了丙戊酰酪氨酸二肽Tyr-Tyr-VPA,粗产率86.7%,其结构经IR和ESI-MS表征。     

三氯氧磷辅助下缬氨酸的自组装成肽反应

多肽多数具有较强的生物活性,可作为药物或药物前体.关于多肽的合成,目前主要有固相合成法、酶促合成法和经典的氨基酸保护合成法.我们发现,在无机磷试剂辅助下α-氨基酸可发生自组装成肽反应,得到一系列多肽产物[1,2].     

钯催化氟磺酸酚酯Suzuki反应合成三联苯类化合物

发展了一个高效、简便合成三联苯类化合物的方法。以氯化钯为催化剂,碳酸钾与三乙胺为碱,无需加入任何配体,在乙醇水溶液中催化氟磺酸联苯酚酯与芳基硼酸的Suzuki反应,可高效合成含有多种官能团的三联苯类化合物。该方法操作简便,无需氮气保护;且芳基硼酸自偶联副产物少,有利于产品的分离。为三联苯类化合物的合成提供了一条简便而高效的途径。     

一步法合成多羟基酚酸芳基酯

一些多羟基酚酸芳基酯具有显著的生理活性,可用于医药、饮料和食品等方面。但目前关于多羟基酚酸芳基酯的合成还研究得不多。传统的方法是(1)保护多羟基酚酸中的酚羟基,(2)活化羧基成酰氯,(3)酯化,(4)去保护基的四步方法。本文将报道多羟基酚酸——2.4——二羟基苯甲酸(1)直接与酚类成酯的反应。即将二氯磷酸芳基酯(ROPOCI_2)(3)作为缩合剂,应用于一步法合成(1)芳基酯,以较好产率得到了(1)的七个新芳基酯(2_a—2_g),并经元素分析及波谱鉴定。同时还首次研究了缩合剂     

"一锅法"简便合成一芳基硼酸和二芳基硼酸

本文改进了一芳基硼酸和二芳基硼酸的制备方法. 利用芳卤, 镁屑, 硼酸三正丁酯或三氟化硼乙醚溶液在室温下"一锅"反应简便合成一芳基硼酸和二芳基硼酸, 分离产率为48～80% .     

手性联硼酸酯介导、实用的不对称异喹啉还原偶联反应

正J.Am.Chem.Soc.2017,139,9767～9770联硼化合物作为制备芳基或烷基硼酸酯的重要合成原料被广泛应用于工业中,而利用其还原性在无过渡金属参与下实现碳碳键构建则鲜有报道.利用简便易得的手性联硼酸酯实现高立体选择性的偶联反应将是很有吸引力的有机合成方法.手性双异喹啉既可以作为相转移催化剂,又是重要的手性配体骨架,而现有的手性双异喹啉的合成方     

环状单胺基卡宾-铑立体选择性地催化氢化(杂)芳基硼酸酯:合成顺式硼化环烷烃和饱和杂环化合物

<正>Angew. Chem. Int. Ed. 2019, 58, 6554～6558在合成化学中,顺式硼基取代的环烷烃和饱和杂环化合物通常难以制备.催化氢化是现代合成化学最重要的手段和策略之一,已被广泛应用于医药、农药等功能分子的合成.值得注意的是,以商业易得的(杂)芳基硼酸酯为原料,对不饱和的芳环进行去芳构化催化加氢面临脱硼化副反应,具有一定的挑战性.四川大学化学学院曾小明课题组发展了一类谐二甲基取代的环状单胺基卡宾-铑催化剂,以廉价易得的(杂)芳基硼酸酯为原料,通过去芳构化催化氢化     

多肽新药研发策略研究进展

多肽药物具有生物活性高、药用剂量小、产业化开发优势明显等诸多优点,已成为全球关注的创新药物研发热点之一.但是其代谢不稳定、半衰期短及较难通透组织屏障等缺点严重阻碍了多肽新药在临床治疗中的广泛应用.为了解决这些限制多肽药物的瓶颈,本课题组发展了一系列的改造策略.通过这些策略的应用,以期加快多肽药物临床应用的步伐.本文主要结合本课题组的工作对多肽新药创制过程中所遇到的关键问题及解决思路进行综述.     

Response of peptide intensity to concentration in ESI–MS-based proteome

High-throughput quantification with label-free methods has received considerable attention in electrospray ionization(ESI)-mass spectrometry(MS),but the manner by which MS signals respond to peptide concentration remains unclear in proteomics.We developed a new mathematical formula to describe the intrinsic log-log relationship between the MS intensity response and peptide concentration in an analytical ESI process.Experimental results showed that the calibration curve is fairly fit to the log-log formula with a linear dynamic range of approximate four to five orders of magnitude.However,we found that the ionization of analytical peptides can be severely suppressed by coexisting matrix peptides,such that the calibration curve can be poorly leveled off on both ends.Our study suggests that the interferences from coexisting matrix peptides should be reduced in the ESI process to use the log-log calibration curve successfully for the high-throughput quantification.     

HF‐Free Boc Synthesis of Peptide Thioesters for Ligation and Cyclization

We have developed a convenient method for the direct synthesis of peptide thioesters, versatile intermediates for peptide ligation and cyclic peptide synthesis. The technology uses a modified Boc SPPS strategy that avoids the use of anhydrous HF. Boc in situ neutralization protocols are used in combination with Merrifield hydroxymethyl resin and TFA/TMSBr cleavage. Avoiding HF extends the scope of Boc SPPS to post‐translational modifications that are compatible with the milder cleavage conditions, demonstrated here with the synthesis of the phosphorylated protein CHK2. Peptide thioesters give easy, direct, access to cyclic peptides, illustrated by the synthesis of cyclorasin, a KRAS inhibitor.     

PepPro: A Nonredundant Structure Data Set for Benchmarking Peptide–Protein Computational Docking

We present a nonredundant benchmark, coined PepPro, for testing peptide–protein docking algorithms. Currently, PepPro contains 89 nonredundant experimentally determined peptide–protein complex structures, with peptide sequence lengths ranging from 5 to 30 amino acids. The benchmark covers peptides with distinct secondary structures, including helix, partial helix, a mixture of helix and β-sheet, β-sheet formed through binding, β-sheet formed through self-folding, and coil. In addition, unbound proteins' structures are provided for 58 complexes and can be used for testing the ability of a docking algorithm handling the conformational changes of proteins during the binding process. PepPro should benefit the docking community for the development and improvement of peptide docking algorithms. The benchmark is available at http://zoulab.dalton.missouri.edu/PepPro_benchmark . © 2019 Wiley Periodicals, Inc.     

Structures of the Peptide Leu-Pro-Tyr-Pro and Its Derivatives and the Nicotinamide Part of NADPH by a Semi-Empirical PM3 Method

The capability of peptides Leu-Pro-Tyr-Pro (LPYP), Leu-Pro-Tyr-Pro-Arg (LPYPR), and Ser-Pro-Tyr-Pro-Arg (SPYPR) to occupy the part of the binding site ascribed to NADPH in the active center of 3-hydroxy-3-methylglutaryl-coenzyme-A-reductase was analyzed using results from a semi-empirical PM3 method. The similarity of the peptide structures to NADPH was determined by comparing the relative contribution from projections of selected bond lengths in the peptides in two mutually perpendicular planes to the corresponding bond lengths in the nicotinamide part of the substrate. The correlation coefficient between the calculated average values of the relative contributions of the bonds and the inhibitory activity of these peptides is rather high (R = 0.926). This indicates that these peptides can occupy the part of the binding site for NADPH in the active center of the enzyme.__________Translated from Khimiya Prirodnykh Soedinenii, No. 1, pp. 56–59, January–February, 2005.     

多肽片段连接方法及肽硫酯和肽醛的合成*

本文综述了多肽和蛋白质合成中的片段连接方法,这是近年来多肽和蛋白质合成领域中方法学上的重要进展.该方法使用非保护的多肽片段,无需酶或化学活化试剂,在缓冲溶液中能够高产率地获得多肽和蛋白质.还介绍了与多肽片段连接有关的肽硫酯和肽醛的合成方法.     

The Synthesis of a Novel Phosphorus Containing Antigen

The hydrolysis of peptide is one of the most important chemical processes in life chemistry. It is of great significance to study catalytic antibody, which is capable of catalyzing the hydrolysis on a specific peptide bond. In recent years, we have successfully synthesized some tetrahedral geometry analogues mimicking that of the hippuryl phenylalanine 1 hydrolyzing transition state catalyzed by carboxypeptidase A(CPA)1,2, which is specific for cleavage of the C-terminal amino acid from an o…     

Current Synthetic Routes to Peptidyl Mono-Fluoromethyl Ketones (FMKs) and Their Applications

Peptidyl mono-fluoromethyl ketones (FMKs) are a class of biologically active molecules that show potential as both protease inhibitors for the treatment of a range of diseases and as chemical probes for the interrogation of cellular processes. This review describes the current solid- and solution-phase routes employed for the synthesis of peptidyl mono-FMKs. In addition, it provides a brief overview of some of the key applications of FMKs in the fields of chemical biology and medicinal chemistry.     

蛋白酶在有机合成中应用的新进展

介绍了有机溶剂中酶促反应的一些基本概念, 总结了酶促反应的发展情况, 归纳了近几年来将蛋白酶应用于有机合成的一些新策略。     

Diaminodiacid Bridges to Improve Folding and Tune the Bioactivity of Disulfide‐Rich Peptides

Disulfide‐rich peptides containing three or more disulfide bonds are promising therapeutic and diagnostic agents, but their preparation is often limited by the tedious and low‐yielding folding process. We found that a single cystine‐to‐diaminodiacid replacement could significantly increase the folding efficiency of disulfide‐rich peptides and thus improve their production yields. The practicality of this strategy was demonstrated by the synthesis and folding of derivatives of the μ‐conotoxin SIIIA, the preclinical hormone hepcidin, and the trypsin inhibitor EETI‐II. NMR and X‐ray crystallography studies confirmed that these derivatives of disulfide‐rich peptide retained the correct three‐dimensional conformations. Moreover, the cystine‐to‐diaminodiacid replacement enabled structural tuning, thereby leading to an EETI‐II derivative with higher bioactivity than the native peptide.